Mullica Hill, NJ, United States of America

John Redman

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Celator Pharmaceuticals, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Redman. Retrieved from https://idiyas.com/inventor/john-redman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by John Redman

Introduction

John Redman is a notable inventor based in Mullica Hills, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative approaches. His work primarily focuses on developing effective drug combinations for solid tumors.

Latest Patents

John Redman holds a patent for "Fixed ratio drug combination treatments for solid tumors." This patent describes methods for treating cancer by administering a pharmaceutical composition that comprises a fixed, non-antagonistic molar ratio of irinotecan and floxuridine. Such methods are particularly useful in treating cancer patients with advanced solid tumors. He has 1 patent to his name.

Career Highlights

John Redman is associated with Celator Pharmaceuticals, Inc., where he has been instrumental in advancing cancer treatment methodologies. His work has garnered attention for its potential to improve patient outcomes in oncology.

Collaborations

He has collaborated with notable colleagues, including Andrew S. Janoff and Lawrence D. Mayer, to further enhance the research and development of cancer therapies.

Conclusion

John Redman's innovative contributions to cancer treatment exemplify the impact of dedicated inventors in the medical field. His work continues to inspire advancements in oncology and improve the lives of patients facing challenging diagnoses.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…